Analyst Ratings For Immutep (NASDAQ:IMMP) (NASDAQ:IMMP)
Today, Maxim Group initiated coverage on Immutep (NASDAQ:IMMP) (NASDAQ:IMMP) with a Buy with a price target of $5.00.
Some recent analyst ratings include
- 3/22/2018-Maxim Group initiated coverage with a Buy rating.
- 4/19/2017-FBR & Co Reiterated Rating of Buy.
- 8/26/2016-Roth Capital Reiterated Rating of Buy.
Recent Trading Activity for Immutep (NASDAQ:IMMP) (NASDAQ:IMMP)
Shares of Immutep (NASDAQ:IMMP) closed the previous trading session at 1.91 up +0.03 1.59% with 1.8799999952316284 shares trading hands.